Orchid Cellmark has several accredited locations worldwide.
January 14, 2010
ORCHID CELLMARK TO CONSOLIDATE U.S. FORENSICS TESTING AT DALLAS FACILITY
Plant and operational savings expected to reach approximately $1.4 million annually
December 14, 2009
U.K. POLICE FORCE VETERAN, DR. JAMES M. HART, TO JOIN ORCHID CELLMARK BOARD OF DIRECTORS
October 29, 2009
ORCHID CELLMARK TO PRESENT TO THE HARVARD INVESTORS GROUP
Investor Presentation Scheduled for Wednesday, November 4, 2009
October 29, 2009
ORCHID CELLMARK REPORTS THIRD QUARTER 2009 FINANCIAL RESULTS
Strong gains posted in U.K. and U.S. forensic casework revenues
October 22, 2009
ORCHID CELLMARK TO ANNOUNCE THIRD QUARTER 2009 FINANCIAL RESULTS ON OCTOBER 29, 2009
October 20, 2009
ORCHID CELLMARK TO CONSOLIDATE U.S. PATERNITY TESTING AT OHIO FACILITY
Plant and operational savings expected to reach approximately $1 million annually
October 13, 2009
ORCHID CELLMARK ANNOUNCES $1 MILLION WORLDWIDE LICENSING AGREEMENT TO COMMERCIALIZE NUCLEOTIDE EXTENSION TECHNOLOGY
September 29, 2009
WASHINGTON STATE SELECTS ORCHID CELLMARK AS SOLE CODIS SUPPLIER
September 8, 2009
ORCHID CELLMARK COMMENCES WORK ON FORENSIC DNA TESTING CONTRACT FOR ONE OF THE UNITED KINGDOM'S LARGEST POLICE FORCES
July 30, 2009
ORCHID CELLMARK REPORTS SECOND QUARTER 2009 FINANCIAL RESULTS
Forensic casework revenue increases significantly; cash grows to $16.6 million
July 23, 2009
ORCHID CELLMARK TO ANNOUNCE SECOND QUARTER 2009 FINANCIAL RESULTS ON JULY 30, 2009
May 7, 2009
ORCHID CELLMARK REPORTS IMPROVED FIRST QUARTER 2009 FINANCIAL RESULTS
Worldwide Forensic Casework Revenues Grow Significantly
April 29, 2009
Orchid Cellmark to present at the 2009 Bank of America Health Care Conference on May 13th
April 27, 2009
Orchid Cellmark to announce first quarter 2009 financial results on May 7, 2009
March 16, 2009
ORCHID CELLMARK REPORTS FOURTH QUARTER AND FULL YEAR 2008 FINANCIAL RESULTS
March 6, 2009
Orchid Cellmark to announce fourth quarter and year-end 2008 financial results on March 16, 2009
October 30, 2008
Orchid Cellmark Reports Third Quarter 2008 Financial Results
October 24, 2008
Orchid Cellmark to Announce Third Quarter 2008 Financial Results on October 30, 2008
July 31, 2008
ORCHID CELLMARK REPORTS SECOND QUARTER 2008 FINANCIAL RESULTS
--U.S. Business Shows 9% Increase In Revenues--
--Florida Upholds Contract Award To Orchid Cellmark For Multi-Year Paternity Testing--
--Regional Tender Work Underway In U.K.--
July 24, 2008
ORCHID CELLMARK TO ANNOUNCE SECOND QUARTER 2008 FINANCIAL
RESULTS ON JULY 31, 2008
July 16, 2008
FLORIDA'S DEPARTMENT OF REVENUE UPHOLDS CONTRACT AWARD TO ORCHID CELLMARK FOR MULTI-YEAR PATERNITY TESTING
-- POTENTIAL CONTRACT VALUE OF $1.2 MILLION ANNUALLY--
June 11, 2008
Orchid Cellmark Launches new Paternity and DNA Testing Web Site
-- www.orchidcellmark.com --
May 27, 2008
Orchid Cellmark Appoints Jeffrey S. Boschwitz as Vice President, North America Marketing & Sales
May 12, 2008
Orchid Cellmark to present at the 2008 Bank of America Health Care Conference
May 8, 2008
Orchid Cellmark reports first quarter 2008 financial results
U.S. Business Shows 21% Increase in Revenues and Notable Improvement in Gross Margin. Major Contracts Signed in U.K. With Potential Value of $10 Million.
May 1, 2008
Orchid Cellmark to announce first quarter 2008 financial results on May 8, 2008
April 30, 2008
Orchid Cellmark signs contracts to provide forensic services for U.K. police forces under newly-awarded regional forensic tender
As a Result of its Success in the North West/South West and Wales Regional Tender, the Company Has Begun Providing the Police with Forensic Services That Have a Potential Value of $10 Million Annually
April 21, 2008
Orchid Cellmark to open a new forensic facility in the United Kingdom to meet increasing demand for its services
New Facility to be Opened in the North West of England
April 18, 2008
Orchid Cellmark applauds expansion of federal forensic DNA identity testing to include all arrestees
New Federal Rules Authorizing DNA Testing of Federal Arrestees Expected to Boost Law Enforcement’s Ability to Combat Crime Complements Recent Moves by States to Expand their DNA Database
March 6, 2008
Orchid Cellmark reports fourth quarter and full year 2007 financial results
February 29, 2008
Orchid Cellmark to announce first quarter 2008 financial results on May 8, 2008
November 20, 2007
Orchid Cellmark appoints William J. Thomas Vice President and General Counsel
November 1, 2007
Orchid Cellmark reports third quarter 2007 financial results
Operating Loss Decreases by 27% Compared to the Third Quarter of 2006. Cash Increases by $650 Thousand During the Quarter.
October 31, 2007
Orchid Cellmark announces closing of acquisition of Reliagene Technologies, Inc.
October 22, 2007
Orchid Cellmark to purchase Reliagene Technologies, Inc.
October 15, 2007
Orchid Cellmark to announce third quarter 2007 financial results on November 1, 2007
October 9, 2007
Orchid Cellmark appoints James F. Smith as chief Financial Officer
August 2, 2007
Orchid Cellmark reports second quarter 2007 financial results
Revenues Increase by 16% and Operating Loss Decreases by 83% Compared to the Second Quarter of 2006
July 26, 2007
Orchid Cellmark to announce second quarter 2007 financial results on August 2, 2007
July 10, 2007
Orchid Cellmark's forensic DNA testing services aid in exoneration of NJ man wrongfully convicted of brutal rape and murder
Pro Bono Laboratory Services Supplied to the Innocence Project Help in Freeing Another Wrongfully Convicted Individual After Years of Incarceration
May 3, 2007
Orchid Cellmark reports first quarter 2007 financial results
2007 First Quarter Operating Loss Reduced to $1.6 Million Compared to 2006 First Quarter Operating Loss of $6.4 Million. Cash Used by Operations Reduced to $57 Thousand.
April 30, 2007
Orchid Cellmark to announce first quarter 2007 financial results on May 3, 2007
March 12, 2007
First test of rapid DNA analysis pioneered by Washington State and Orchid Cellmark identifies alleged child rapist within days
Pilot Program Reduces DNA Testing Turnaround Time from Months to Days; First Application Provides Dramatic Proof of Successful Concept
March 9, 2007
Orchid Cellmark appoints Bruce Basarab as Vice President of north american Sales and Marketing
March 8, 2007
Orchid Cellmark reports fourth quarter and full year 2006 financial results
2006 Fourth Quarter Operating Loss Reduced to Under $1 Million Compared to 2005 Fourth Quarter Operating Loss of $5.3 Million
February 22, 2007
Orchid Cellmark to announce fourth quarter and full year 2006 financial results on March 8, 2007
